—
Active implantable devices market has shown strong growth pattern in recent year’s majorly due to increasing incidence & prevalence of cardiovascular diseases, various technological advancements, increasing neurological disorders with greying population, and expanded application of neurostimulators for chronic pain therapy. Furthermore, huge investments by the market leaders and foraying of new companies into this market, wide scope of penetration in untapped emerging markets, and rising awareness among people about active implantable devices therapy are also accelerating the growth of this market.Meticulous Research® in its latest publication on active implantable devices market states that the global active implantable devices market will increase at a CAGR of 6.7% from 2017 to 2022 to reach USD 24,024.0 million by 2022. Wherein, geographically, North America commanded the largest share in this market followed by Europe. The major share of North America is mainly attributed to increasing incidence of cardiovascular diseases and neurological disorders with rising greying population, and expanded application of neurostimulators for chronic pain therapy; well-established healthcare system & distribution channel; higher spending on healthcare; and presence of leading players in the market.
Download free sample report and gain crucial industry insights @https://www.meticulousresearch.com/download-sample-report/cp_id=3539
The report provides meticulous analysis of global active implantable devices market by segmenting it on the basis of product type (Implantable Cardioverter Defibrillators (ICDs), implantable cardiac pacemakers, neuromodulators, ventricular assist devices, implantable hearing devices, and implantable heart monitors/insertable loop recorders). Wherein, among product types, Implantable Cardioverter Defibrillators (ICDs) segment commanded the largest share in this market majorly due to rising adoption of ICDs for the prevention of sudden cardiac deaths (SCD) in patients at high risk for SCD with increasing incidence of cardiac arrest and atrial fibrillation, and increasing burden of high blood pressure.
The key players analyzed in the global active implantable devices market are Medtronic plc (Ireland), Abbott Laboratories (U.S.), Boston Scientific Corporation (U.S.), BIOTRONIK SE & Co. KG (Germany), and LivaNova PLC (U.K.), Cochlear Limited (Australia), MED-EL (Austria), Sonova Holding AG (Switzerland), William Demant Holding A/S (Denmark), and Nurotron Biotechnology Co., Ltd. (China).
Browse in-depth Report on: https://www.meticulousresearch.com/product/active-implantable-devices-market-2022/
Key Topics Covered in This Report:
1. Introduction
1.1. Market Ecosystem
1.2. Currency and Limitations
1.2.1. Currency
1.2.2. Limitations
1.3. Key Stakeholders
2. Research Methodology
2.1. Research Process
2.1.1. Secondary Research
2.1.2. Primary Research
2.1.3. Market Size Estimation
3. Executive Summary
4. Market insights
4.1. Introduction
4.2. Drivers
4.2.1. Increasing Burden of Cardiovascular Diseases
4.2.2. Rising Prevalence of Neurological Disorders
4.2.3. Growing Investments and Funds to Develop Technologically Advanced Products
4.2.4. Expanded Applications of Neurostimulators
4.3. Restraints
4.3.1. Stringent Regulation for Approvals & Rising Product Recalls
4.3.2. Issues Related to the Use of Implantable Medical Devices
4.3.3. High Cost of Implants and an Unfavorable Reimbursement Scenario
4.4. Opportunities
4.4.1. Emerging Markets offer Significant Growth Opportunities
4.5. Challenges
4.5.1. Increasing Pricing Pressure on Market Players
4.5.2. Lack of Skilled Professionals
4.6. Regulatory Analysis
4.6.1. North America
4.6.2. Europe
4.6.3. Asia-Pacific
4.6.4. Rest of World
4.7. Active Implantable Devices Market Share Analysis by Key Players
4.7.1. Active Implantable Cardiovascular Devices Market
4.7.2. Neurostimulators Market
4.7.3. Active Implantable Hearing Devices Market
5. Active Implantable Devices Market, by Product
5.1. Introduction
5.2. Implantable Cardioverter Defibrillator
5.2.1. Transvenous Implantable Cardioverter Defibrillator
5.2.1.1. Biventricular Implantable Cardioverter Defibrillator
5.2.1.2. Dual-Chamber Implantable Cardioverter Defibrillators
5.2.1.3. Single-Chamber Implantable Cardioverter Defibrillators
5.2.2. Subcutaneous Implantable Cardioverter Defibrillators
5.3. Implantable Cardiac Pacemakers
5.4. Ventricular Assist Devices
5.5. Implantable Heart Monitors/insertable Loop Recorders
5.6. Neurostimulators
5.6.1. Spinal Cord Stimulators
5.6.2. Deep Brain Stimulators
5.6.3. Sacral Nerve Stimulators
5.6.4. Vagus Nerve Stimulators
5.6.5. Gastric Electrical Stimulators
5.7. Implantable Hearing Devices
6. Active Implantable Devices Market, by Geography
6.1. Introduction
6.2. North America
6.2.1. U.S.
6.2.2. Canada
6.3. Europe
6.3.1. Germany
6.3.2. France
6.3.3. U.K.
6.3.4. Italy
6.3.5. Spain
6.3.6. RoE
6.4. Asia-Pacific
6.4.1. Japan
6.4.2. China
6.4.3. India
6.4.4. RoAPAC
6.5. RoW
6.5.1. Latin America
6.5.2. Middle East & Africa
7. Competetive Landscape
7.1. Approvals
7.2. New Product Launch
7.3. Mergers & Acquistions
7.4. Expansions
7.5. Partnerships, Collaborations & Agreements
8. Company Profiles (Business Overview, Financials, Product Portfolio, Recent Developments)
8.1. Medtronic Plc
8.2. Boston Scientific Corporation
8.3. BIOTRONIK SE & CO., KG
8.4. LivaNova Plc
8.5. William Demant Holding A/S
8.6. Cochlear Ltd.
8.7. Sonova Holding AG
8.8. MED-EL
8.9. Nurotron Biotechnology Co. Ltd.
8.10. Nuvectra Corporation
8.11. Abbott Laboratories
9. Appendix
9.1. Questionnaire
9.2. Available Customization
Download free sample report and gain crucial industry insights @https://www.meticulousresearch.com/download-sample-report/cp_id=3539
Contact Info:
Name: Khushal
Email: Send Email
Organization: Meticulous Market Research Pvt.Ltd
Address: Pune, India
Phone: +91-744-778-0008
Website: https://www.meticulousresearch.com/product/active-implantable-devices-market-2022/
Release ID: 88890294
Google
RSS